Insider · CIK 0001738081

Mostafa Adam S.

CIK 0001738081 Name as filed on the most recent filing

Filed as Mostafa Adam S. (21)

21 transaction lines · from 21 filings · filed 2020-07-01 to 2025-01-27 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

21 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-25 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-01-24 S, Open-market sale X4 Pharmaceuticals, IncXFOR 33,947, disposed Open Form 4 filing 0001628280-25-002708
2024-10-07 S, Open-market sale X4 Pharmaceuticals, IncXFOR 126,901, disposed Open Form 4 filing 0001628280-24-042545
2024-03-11 S, Open-market sale X4 Pharmaceuticals, IncXFOR 46,347, disposed Open Form 4 filing 0001628280-24-010279
2024-02-12 S, Open-market sale X4 Pharmaceuticals, IncXFOR 27,973, disposed Open Form 4 filing 0001628280-24-004263
2023-11-01 S, Open-market sale X4 Pharmaceuticals, IncXFOR 168,371, disposed Open Form 4 filing 0001628280-23-036758
2023-06-30 S, Open-market sale X4 Pharmaceuticals, IncXFOR 4,991, disposed Open Form 4 filing 0001628280-23-024228
2023-06-23 S, Open-market sale X4 Pharmaceuticals, IncXFOR 10,455, disposed Open Form 4 filing 0001628280-23-023443
2023-06-15 S, Open-market sale X4 Pharmaceuticals, IncXFOR 12,026, disposed Open Form 4 filing 0001628280-23-022473
2023-03-10 S, Open-market sale X4 Pharmaceuticals, IncXFOR 44,100, disposed Open Form 4 filing 0001628280-23-007722
2023-02-13 S, Open-market sale X4 Pharmaceuticals, IncXFOR 25,781, disposed Open Form 4 filing 0001628280-23-003757
2022-08-17 S, Open-market sale X4 Pharmaceuticals, IncXFOR Not reported Open Form 4 filing 0001628280-22-023323
2022-06-30 S, Open-market sale X4 Pharmaceuticals, IncXFOR Not reported Open Form 4 filing 0001628280-22-018400
2022-06-24 S, Open-market sale X4 Pharmaceuticals, IncXFOR Not reported Open Form 4 filing 0001628280-22-018047
2022-06-16 S, Open-market sale X4 Pharmaceuticals, IncXFOR Not reported Open Form 4 filing 0001628280-22-017438
2022-02-11 S, Open-market sale X4 Pharmaceuticals, IncXFOR Not reported Open Form 4 filing 0001628280-22-002511
2021-08-17 S, Open-market sale X4 Pharmaceuticals, IncXFOR 55,243, disposed Open Form 4 filing 0001628280-21-017333
2021-06-30 S, Open-market sale X4 Pharmaceuticals, IncXFOR 17,536, disposed Open Form 4 filing 0001628280-21-013299
2021-06-24 S, Open-market sale X4 Pharmaceuticals, IncXFOR 37,973, disposed Open Form 4 filing 0001628280-21-012933
2021-06-15 S, Open-market sale X4 Pharmaceuticals, IncXFOR 42,469, disposed Open Form 4 filing 0001628280-21-012477
2020-09-21 S, Open-market sale X4 Pharmaceuticals, IncXFOR 76,705, disposed Open Form 4 filing 0001628280-20-013832
2020-06-30 S, Open-market sale X4 Pharmaceuticals, IncXFOR 15,594, disposed Open Form 4 filing 0001628280-20-010103

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 21
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Mostafa Adam S., insider transactions. Retrieved 2026-08-25 from https://ebomi.com/insider/0001738081

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.